311 related articles for article (PubMed ID: 22832501)
1. Effect of aggressively driven intravenous iron therapy on infectious complications in end-stage renal disease patients on maintenance hemodialysis.
Bansal A; Sandhu G; Gupta I; Kalahalli S; Nayak R; Zouain E; Chitale RA; Meisels I; Chan G
Am J Ther; 2014; 21(4):250-3. PubMed ID: 22832501
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive vision for intravenous iron therapy.
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
[TBL] [Abstract][Full Text] [Related]
3. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
[TBL] [Abstract][Full Text] [Related]
5. Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.
Macdougall IC; White C; Anker SD; Bhandari S; Farrington K; Kalra PA; McMurray JJV; Murray H; Steenkamp R; Tomson CRV; Wheeler DC; Winearls CG; Ford I;
Am J Nephrol; 2018; 48(4):260-268. PubMed ID: 30304714
[TBL] [Abstract][Full Text] [Related]
6. Achievement of renal anemia KDIGO targets by two different clinical strategies - a European hemodialysis multicenter analysis.
Drozdz M; Weigert A; Silva F; Frazão J; Alsuwaida A; Krishnan M; Kleophas W; Brzosko S; Johansson FK; Jacobson SH
BMC Nephrol; 2019 Jan; 20(1):5. PubMed ID: 30616548
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
[TBL] [Abstract][Full Text] [Related]
8. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
Larson K
Nephrol Nurs J; 2008; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
[TBL] [Abstract][Full Text] [Related]
9. [Issues related to iron replacement in dialyzed patients].
Kessler M
Nephrol Ther; 2006 Sep; 2 Suppl 4():S266-73. PubMed ID: 17373269
[TBL] [Abstract][Full Text] [Related]
10. New Options for Iron Supplementation in Maintenance Hemodialysis Patients.
Vaziri ND; Kalantar-Zadeh K; Wish JB
Am J Kidney Dis; 2016 Mar; 67(3):367-75. PubMed ID: 26616335
[TBL] [Abstract][Full Text] [Related]
11. National perspective on iron therapy as a clinical performance measure for maintenance hemodialysis patients.
Owen WF; Szczech L; Johnson C; Frankenfield D
Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S5-S11. PubMed ID: 10516369
[TBL] [Abstract][Full Text] [Related]
12. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron dextran treatment in predialysis patients with chronic renal failure.
Dahdah K; Patrie JT; Bolton WK
Am J Kidney Dis; 2000 Oct; 36(4):775-82. PubMed ID: 11007680
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients.
Kshirsagar AV; Li X
Adv Chronic Kidney Dis; 2019 Jul; 26(4):292-297. PubMed ID: 31477259
[TBL] [Abstract][Full Text] [Related]
15. Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.
Deira J; González-Sanchidrián S; Polanco S; Cebrián C; Jiménez M; Marín J; Gómez-Martino JR; Fernández-Pereira L; Tabernero J
Ren Fail; 2016 Aug; 38(7):1076-81. PubMed ID: 27197731
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of renal anemia with iron in hemodialysis patients in General Hospital Bjelovar].
Lovcić V; Vujić J; Basić-Jukić N; Janković RI; Kurtović I; Dzapo M; Lovcić P
Acta Med Croatica; 2011 Oct; 65 Suppl 3():45-8. PubMed ID: 23120815
[TBL] [Abstract][Full Text] [Related]
17. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis.
Susantitaphong P; Alqahtani F; Jaber BL
Am J Nephrol; 2014; 39(2):130-41. PubMed ID: 24513913
[TBL] [Abstract][Full Text] [Related]
19. When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?
Rostoker G
Semin Dial; 2019 Jan; 32(1):22-29. PubMed ID: 29956370
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related Quality of Life in Patients Receiving Hemodialysis.
Freburger JK; Ellis AR; Wang L; Butler AM; Kshirsagar AV; Winkelmayer WC; Brookhart MA
Am J Kidney Dis; 2016 Feb; 67(2):271-82. PubMed ID: 26508682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]